Neoplasms, Second Primary
"Neoplasms, Second Primary" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Abnormal growths of tissue that follow a previous neoplasm but are not metastases of the latter. The second neoplasm may have the same or different histological type and can occur in the same or different organs as the previous neoplasm but in all cases arises from an independent oncogenic event. The development of the second neoplasm may or may not be related to the treatment for the previous neoplasm since genetic risk or predisposing factors may actually be the cause.
Concept/Terms
Neoplasms, Second Primary- Neoplasms, Second Primary
- Neoplasm, Second Primary
- Second Primary Neoplasm
- Metachronous Second Primary Neoplasms
- Neoplasms, Metachronous
- Second Primary Neoplasms, Metachronous
- Second Malignancy
- Malignancies, Second
- Malignancy, Second
- Second Malignancies
- Second Neoplasm
- Neoplasm, Second
- Neoplasms, Second
- Second Neoplasms
- Second Primary Neoplasms
- Metachronous Neoplasms
- Metachronous Neoplasm
- Neoplasm, Metachronous
- Neoplasms, Metachronous Second Primary
Neoplasms, Therapy-Associated- Neoplasms, Therapy-Associated
- Neoplasm, Therapy-Associated
- Neoplasms, Therapy Associated
- Therapy-Associated Neoplasm
- Neoplasms, Treatment-Associated
- Neoplasm, Treatment-Associated
- Neoplasms, Treatment Associated
- Treatment-Associated Neoplasm
- Neoplasms, Treatment-Related
- Neoplasm, Treatment-Related
- Neoplasms, Treatment Related
- Treatment-Related Neoplasm
- Therapy-Related Neoplasms
- Therapy Related Neoplasms
- Treatment-Associated Neoplasms
- Treatment Associated Neoplasms
- Treatment-Related Neoplasms
- Treatment Related Neoplasms
- Neoplasms, Therapy-Related
- Neoplasm, Therapy-Related
- Neoplasms, Therapy Related
- Therapy-Related Neoplasm
- Therapy-Associated Neoplasms
- Therapy Associated Neoplasms
Therapy-Associated Cancer- Therapy-Associated Cancer
- Cancer, Therapy-Associated
- Cancers, Therapy-Associated
- Therapy Associated Cancer
- Therapy-Associated Cancers
- Therapy-Related Cancer
- Cancer, Therapy-Related
- Cancers, Therapy-Related
- Therapy Related Cancer
- Therapy-Related Cancers
- Treatment-Related Cancer
- Cancer, Treatment-Related
- Cancers, Treatment-Related
- Treatment Related Cancer
- Treatment-Related Cancers
- Treatment-Associated Cancer
- Cancer, Treatment-Associated
- Cancers, Treatment-Associated
- Treatment Associated Cancer
- Treatment-Associated Cancers
Cancer, Second Primary- Cancer, Second Primary
- Cancers, Second Primary
- Second Primary Cancer
- Second Primary Cancers
- Second Cancer
- Cancer, Second
- Cancers, Second
- Second Cancers
Below are MeSH descriptors whose meaning is more general than "Neoplasms, Second Primary".
Below are MeSH descriptors whose meaning is more specific than "Neoplasms, Second Primary".
This graph shows the total number of publications written about "Neoplasms, Second Primary" by people in Harvard Catalyst Profiles by year, and whether "Neoplasms, Second Primary" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 7 | 3 | 10 |
1995 | 3 | 4 | 7 |
1996 | 4 | 1 | 5 |
1997 | 7 | 4 | 11 |
1998 | 5 | 7 | 12 |
1999 | 7 | 1 | 8 |
2000 | 8 | 8 | 16 |
2001 | 9 | 3 | 12 |
2002 | 7 | 4 | 11 |
2003 | 13 | 2 | 15 |
2004 | 10 | 2 | 12 |
2005 | 15 | 6 | 21 |
2006 | 11 | 4 | 15 |
2007 | 23 | 3 | 26 |
2008 | 20 | 5 | 25 |
2009 | 17 | 5 | 22 |
2010 | 11 | 5 | 16 |
2011 | 17 | 6 | 23 |
2012 | 23 | 7 | 30 |
2013 | 12 | 2 | 14 |
2014 | 22 | 2 | 24 |
2015 | 22 | 3 | 25 |
2016 | 27 | 6 | 33 |
2017 | 25 | 4 | 29 |
2018 | 22 | 8 | 30 |
2019 | 20 | 3 | 23 |
2020 | 22 | 5 | 27 |
2021 | 16 | 5 | 21 |
2022 | 37 | 0 | 37 |
2023 | 26 | 0 | 26 |
2024 | 7 | 0 | 7 |
Below are the most recent publications written about "Neoplasms, Second Primary" by people in Profiles.
-
Treatment Access for Gastrointestinal Stromal Tumor in Predominantly Low- and Middle-Income Countries. JAMA Netw Open. 2024 Apr 01; 7(4):e244898.
-
Small myeloid subclones are present at diagnosis of multiple myeloma in patients who develop secondary myelodysplastic syndromes. Haematologica. 2024 Apr 01; 109(4):1289-1292.
-
Synchronous versus metachronous spinal metastasis: a comparative study of survival outcomes following neurosurgical treatment. J Cancer Res Clin Oncol. 2024 Mar 19; 150(3):136.
-
Germline Genetic Testing and Survival Outcomes Among Children With Rhabdomyosarcoma: A Report From the Children's Oncology Group. JAMA Netw Open. 2024 Mar 04; 7(3):e244170.
-
Hypomethylating agents plus venetoclax compared with intensive induction chemotherapy regimens in molecularly defined secondary AML. Leukemia. 2024 Apr; 38(4):762-768.
-
Second Malignant Neoplasms Following Treatment for Hepatoblastoma: An International Report and Review of the Literature. J Pediatr Hematol Oncol. 2024 Mar 01; 46(2):80-87.
-
Redox signalling regulates breast cancer metastasis via phenotypic and metabolic reprogramming due to p63 activation by HIF1a. Br J Cancer. 2024 Apr; 130(6):908-924.
-
Second Malignancy Probabilities in Patients With Breast Cancer Treated With Conventional Versus Hypofractionated External Beam Radiation Therapy in the Adjuvant Setting. Clin Oncol (R Coll Radiol). 2024 03; 36(3):183-192.
-
The New NCI Precision Medicine Trials. Clin Cancer Res. 2023 12 01; 29(23):4728-4732.
-
Advances in radiation therapy for testicular seminoma. World J Urol. 2023 Dec; 41(12):3895-3903.